According to Sonoma Pharmaceuticals's latest financial reports the company's current revenue (TTM ) is $12.69 Million USD. In 2023 the company made a revenue of $12.31 Million USD a decrease over the revenue in the year 2022 that were of $12.55 Million USD. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.